REQUEST A DEMO
Total
USD $0.00
Search more companies

Pexon Poland Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pexon Poland Sp. z o.o. Profile Updated: March 24, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Pexon Poland Sp. z o.o. is a company based in Poland, with its head office in Lublin. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on March 13, 2023. In its most recent financial highlights, the company reported a net sales revenue increase of 39.93% in 2025. Its total assets grew by 190.59% over the same period. In, 2025, the company’s net profit margin decreased by 26.63%.

Headquarters
Ul. Tomasza Zana 11A
Lublin; Lubelskie; Postal Code: 20-601

Contact Details: Purchase the Pexon Poland Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Pexon Poland Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Pexon Poland Sp. z o.o. report to view the information.
Incorporation Date:
March 13, 2023
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
91%
Company Performance
Financial values in the chart are available after Pexon Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
39.93%
Total Operating Revenue
39.72%
Operating Profit
-77.39%
Net Profit/Loss for the Period
-77.58%
Total Assets
190.59%
Total Equity
25.54%
Operating Profit Margin
-28.98%
Net Profit Margin
-26.63%
Return on Equity (ROE)
-93.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?